Real World Evidence for rehabilitation that works — at home.
Quant Holding Zrt. operates a healthcare and rehabilitation ecosystem in Hungary that turns everyday clinical practice into Real World Evidence — across a complete care pathway, from residential rehabilitation to technology-supported ageing in place.
Operating adjacent to Bugát Pál Hospital, Gyöngyös · Three interconnected care programmes · Validated mHealth methodology · Open to international clinical and research partnerships
A CLINICAL OPERATING COMPANY, NOT A TECHNOLOGY VENDOR
Quant Holding Zrt. is not a technology developer. We are a Real World Evidence based clinical operating company: we apply mHealth platforms and IoT devices in daily rehabilitation practice, collect structured data throughout the entire care pathway, and turn that data into validated, evidence-based rehabilitation models.
The mHealth platforms and IoT infrastructure we deploy are developed and supplied by our technology partner, ACYPRO Solutions & Assets Ltd. Our contribution is everything the technology alone cannot deliver: clinical protocols, trained care teams, a functioning care pathway — and the Real World Evidence that proves the model works.
Our operating base is deliberately located next to Bugát Pál Hospital, the regional hospital in Gyöngyös. This places our programmes at the exact point where patients transition from inpatient care back to their own homes — the phase where structured rehabilitation matters most and oversight typically drops away fastest.
ONE CARE PATHWAY, THREE PROGRAMMES
Vitalitas Rezidence — The Gateway.
A short-term residential programme of education and complex rehabilitation. In a clinically supervised setting, clients rebuild physical function and acquire the digital health competence that enables them to live — and remain — at home. The residential stay is preparation, not destination: its purpose is to make permanent institutional placement avoidable.
Telemonitoring — The Foundation.
The technology and safety layer of home-based care: continuous IoT monitoring, alerting, and structured data collection in the client's own home, forming the safety net beneath professional home nursing.
Matra Home Care Living Lab — The Continuum.
Long-term, home-based active elderly care that keeps rehabilitation outcomes alive where people actually live — supporting ageing in place with clinical-grade monitoring and structured interventions.
Each programme feeds the next, and every stage generates structured, comparable clinical data. That is what makes the ecosystem more than a service portfolio: it is a longitudinal evidence engine.
PROVEN MODELS, READY FOR ADAPTATION
By combining professional home care delivery with validated eHealth methods, we create service models that can be licensed, replicated, and adapted by healthcare providers, insurers, research institutions, and operators in other markets. This addresses workforce and demographic pressures in the silver economy across Europe, including Switzerland. We do not sell promises; we demonstrate viability in daily operation, with data.
Strategic partnership conversations are in progress with Bravecare, an international home care group operating across multiple European countries, regarding knowledge exchange, pilot integration and possible cross-border collaboration in rehabilitation and elderly care.
FAQ
What does Quant Holding Zrt. do?
Quant Holding operates a Real World Evidence based rehabilitation ecosystem in Hungary. It applies partner-developed mHealth technology in clinical practice across three interconnected programmes — Vitalitás Rezidence, Telemonitoring and Mátra Home Care Living Lab — collects structured outcome data, and develops validated, transferable care models offered to healthcare organisations on a B2B basis.
Is Quant Holding a technology company?
No. Quant Holding is a clinical operator. The underlying mHealth platforms and IoT devices are developed and supplied by ACYPRO Solutions & Assets Ltd.; Quant Holding contributes the clinical protocols, service operation, data collection and clinical validation that turn technology into a working care pathway.
What does Real World Evidence mean in this context?
Real World Evidence (RWE) is clinical evidence derived from structured data collected during routine care delivery — continuous monitoring, standardised assessments and adherence tracking across the full care pathway — rather than from controlled laboratory settings. It shows how a rehabilitation model performs with real patients, in real homes, over time.
Who leads Quant Holding?
Quant Holding is led by Dr. Fanni Zsarnóczky-Dulházi, CEO — a clinical kinesiologist and complex rehabilitation specialist with a PhD and targeted hospital experience, who translates research-grade methodology into scalable clinical operations.
Looking for a validated home rehabilitation model — or a pilot partner in Central Europe?
Book a meeting, or send a written enquiry. Replies within two business days, reviewed personally.
ACADEMIC AND CLINICAL FOUNDATION
Dr. Zsarnóczky-Dulházi holds a PhD from the Hungarian University of Sports Science ("Application, Testing and Development of New Infocommunication Technologies in Rehabilitation"). Her doctoral research examined how digital tools perform in real rehabilitation use: sensory strategies in balance control, smartphone-based self-monitoring of exercise technique validated with older adults, and AI-based markerless motion analysis benchmarked against reference systems.
The finding she has carried into practice: older adults can use real-time digital feedback as reliably as younger adults — when the tool is designed for the task. Her clinical work spans complex rehabilitation with a focus on elderly and post-acute populations, grounded in hospital-setting experience.
Dr. Fanni Zsarnóczky-Dulházi, PhD, kinesiologist & complex rehabilitation specialist, leads Quant Holding Zrt. as chief executive and clinical director of its rehabilitation ecosystem. A clinical kinesiologist and complex rehabilitation specialist with a PhD and targeted hospital experience, she is responsible for one specific transformation: translating research-grade methodology into a functioning, scalable operating system for care.
FROM RESEARCH TO A WORKING SYSTEM
Most rehabilitation research stops at publication. Dr. Zsarnóczky-Dulházi's work starts there. As CEO of Quant Holding, she designs the clinical protocols, measurement frameworks and care pathways through which the ecosystem's three programmes operate — and through which every client interaction produces structured, comparable data. The result is a care pathway that is simultaneously a service and an evidence engine: clinically led, methodologically documented, and built to scale beyond a single site or a single country.
Selected co-author publications:
AI-Based Motion Analysis Software for Sport and Physical Therapy Assessment
Promising European research results to improve hospitality in healthcare by eHealth
Presentation of cross-border health tourism processes through the example of North America
Effect of sports background on the visual and vestibular signal processing abilities of athletes
Goniométer alkalmazás használata gyakorlatvégrehajtás során
Az elektronikus egészségügy technológiai háttere és megjelenése a rehabilitációban
OPEN TO COLLABORATION
Dr. Zsarnóczky-Dulházi is actively open to clinical, research and institutional partnerships — joint pilots, methodology exchange, cross-border service adaptation and co-authored evaluation work. Working language: English.
HOW WE WORK
How three programmes, one methodology, and thousands of structured data points become a validated rehabilitation model.
THE DIVISION OF ROLES: TECHNOLOGY ENABLES, CLINICAL OPERATION VALIDATES
The mHealth platforms and IoT devices used across our ecosystem are developed and supplied by ACYPRO Solutions & Assets Ltd., our technology partner. Quant Holding's role begins where the technology ends: we design the clinical protocols, operate the services, train the care teams, collect and structure the data — and produce the Real World Evidence that determines whether a model is worth scaling.
This separation is deliberate. It keeps the technology clinically neutral and the evidence operationally honest: the platform performs the measurement, the clinical organisation defines what is measured, why, and what counts as success.
WHAT WE MEASURE
Functional outcomes on validated clinical scales
Adherence to rehabilitation and monitoring protocols
Safety events and their downstream consequences
Digital health literacy progression — a distinctive, documented outcome of our programmes
Qualitative client and caregiver experience
FROM EVIDENCE TO TRANSFERABLE MODEL
The end product of this methodology is not a report but a transferable service model: a documented care pathway with known outcomes, known costs of operation and known conditions of success — ready to be adapted by hospitals, insurers and care operators in other regulatory and demographic contexts.
FAQ
How does Quant Holding integrate technology into rehabilitation?
Technology from ACYPRO Solutions & Assets Ltd. — mHealth platforms and IoT sensors — is embedded into clinically designed care protocols. The platform captures the data; Quant Holding's clinical framework defines the assessments, interventions and outcome criteria. Integration happens at the protocol level, not as a bolt-on app.
How is data collected and protected?
Data is collected through structured clinical assessments and continuous IoT monitoring, processed under GDPR-compliant procedures. All published evidence is anonymised and aggregated at cohort level; individual patient data is never published or shared.
How is this different from a clinical trial?
Clinical trials test interventions under controlled conditions; our Real World Evidence documents how a complete service model performs in routine operation — with real clients, real homes and real care teams. The two are complementary: RWE answers the question trials cannot, namely whether a model works at operational scale.
The Care Pathway: three programmes, one validated model.
This part presents our operating portfolio from a partner and investor perspective. We are not selling services to patients here; we are demonstrating a working, scalable, clinically validated model to the profession — with each programme playing a defined role in a single, continuous care pathway.
PILLAR 1 — VITALITÁS REZIDENCE · THE GATEWAY
Role in the pathway: structured entry point. A short-term residential preparation phase focused on education and complex rehabilitation, adjacent to the regional hospital in Gyöngyös.
What it does: clients complete a clinically supervised residential phase in which functional capacity is rebuilt, individual intervention plans are established, and — critically — digital health competence is trained. The explicit objective of the residential stay is discharge to the client's own home: participants leave equipped to live independently with technology-supported care, rather than progressing to permanent institutional placement.
What it demonstrates (B2B): a replicable preparation and education model that substitutes long-term institutional care with prepared, technology-supported living at home; clean functional and digital-literacy baselines for every client entering the pathway; and a documented bridge between inpatient care and home-based rehabilitation — with direct cost-of-care implications for payers and providers.
PILLAR 2 — TELEMONITORING · THE FOUNDATION
Role in the pathway: the technology and safety layer beneath all home-based care.
What it does: continuous IoT-based monitoring in the client's own home — physiological trends, activity patterns, safety alerting — combined with structured data collection that feeds the ecosystem's shared evidence base. The Otthonmonitor program is what makes professional home nursing safe, accountable and measurable.
What it demonstrates (B2B): that around-the-clock, real-world data capture can be operated affordably at household level; and that a monitoring layer materially changes the safety and staffing economics of home care — a direct answer to the workforce shortages defining elderly care across Europe.
PILLAR 3 — MÁTRA HOME CARE LIVING LAB · THE CONTINUUM
Role in the pathway: the long-term destination — active, supported ageing in place.
What it does: Hungary's first mHealth-focused elderly home care living lab, delivering clinical-grade monitoring, structured rehabilitation interventions and care coordination in clients' own homes, coordinated from the central Living Lab in Gyöngyös. The underlying mHealth platform is developed and supplied by ACYPRO Solutions & Assets Ltd.
What it demonstrates (B2B): longitudinal, real-world outcome data from a running service — functional trajectories, adherence, digital health literacy progression — and the operational playbook of an mHealth-enabled home care service: staffing, protocols, escalation paths and unit economics.
INTERNATIONAL COLLABORATION
Strategic partnership conversations are in progress with Bravecare, an international home care group operating across multiple European countries, regarding knowledge exchange, pilot integration and possible cross-border collaboration in rehabilitation and elderly care.
FAQ
Can the Quant Holding model be adapted outside Hungary?
Yes — by design. The care pathway is documented as a transferable service model: protocols, measurement frameworks, and operational playbooks are maintained so they can be adapted to other regulatory, reimbursement, and demographic contexts, from Central Europe to Western European and Swiss market conditions.
How do the three programmes relate to each other?
They form one continuous pathway. Vitalitás Rezidence is the short-term residential entry point (assessment, rehabilitation, education) that prepares clients for living at home; Telemonitoring is the permanent technology and safety layer in the home; Mátra Home Care is the long-term home care service that sustains outcomes. Clients move along the pathway, and their data record moves with them.
What can a B2B partner actually buy or license?
Validated service models: the combination of clinical protocols, mHealth methodology, operational know-how and outcome evidence needed to launch or upgrade a technology-supported home rehabilitation service — supported by pilot collaboration and knowledge transfer from a running reference site.
Evaluating a home rehabilitation model for your market? Book a meeting or request our methodology documentation.
Contact us
Quant Holding Zrt.
3200 Gyöngyös, Batsányi János utca 9.